|
SUN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.26629997785489E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.59869999969165E-07 |
| Normal-vs-Stage2 |
1.84652999999368E-05 |
| Normal-vs-Stage3 |
1.54439999677791E-08 |
| Normal-vs-Stage4 |
2.44819999999368E-05 |
| Stage1-vs-Stage2 |
3.085200E-01 |
| Stage1-vs-Stage3 |
6.035600E-02 |
| Stage1-vs-Stage4 |
5.980400E-01 |
| Stage2-vs-Stage3 |
7.433000E-01 |
| Stage2-vs-Stage4 |
6.806600E-01 |
| Stage3-vs-Stage4 |
4.045400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.4050000031225E-09 |
| Normal-vs-AfricanAmerican |
1.841100E-03 |
| Normal-vs-Asian |
5.923900E-02 |
| Caucasian-vs-AfricanAmerican |
6.754200E-01 |
| Caucasian-vs-Asian |
4.815100E-03 |
| AfricanAmerican-vs-Asian |
1.707420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26160000002429E-06 |
| Normal-vs-Female |
1.19669999465444E-08 |
| Male-vs-Female |
7.157600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.19760000000391E-05 |
| Normal-vs-Age(41-60Yrs) |
3.659600000816E-08 |
| Normal-vs-Age(61-80Yrs) |
3.099200007739E-09 |
| Normal-vs-Age(81-100Yrs) |
3.778500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.206000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.459800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.191200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.454600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.521800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.593800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.975400E-03 |
| Classical-VS-Follicular |
3.603400E-03 |
| Classical-VS-Other |
9.982800E-01 |
| Classical-VS-Normal |
2.32739999994624E-06 |
| Tall-VS-Follicular |
8.378400E-01 |
| Tall-VS-Other |
1.882000E-01 |
| Tall-VS-Normal |
1.02929999967749E-07 |
| Follicular-VS-Other |
3.794200E-01 |
| Follicular-VS-Normal |
7.10340000154019E-08 |
| Other-VS-Normal |
9.413700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88079996021884E-09 |
| Normal-vs-N1 |
2.582300E-03 |
| N0-vs-N1 |
6.374200E-02 |
|
|
